Search Results - "Durett, April G"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Manufacturing mesenchymal stromal cells for phase I clinical trials by Hanley, Patrick J, Mei, Zhuyong, da Graca Cabreira-Hansen, Maria, Klis, Mariola, Li, Wei, Zhao, Yali, Durett, April G, Zheng, Xingwu, Wang, Yongping, Gee, Adrian P, Horwitz, Edwin M

    Published in Cytotherapy (Oxford, England) (01-04-2013)
    “…Abstract Mesenchymal stromal cells (MSCs) are multipotent progenitor cells capable of differentiating into adipocytes, osteoblasts and chondroblasts as well as…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Generation of EBV-Specific CD4+ Cytotoxic T Cells from Virus Naive Individuals by Savoldo, Barbara, Cubbage, Michael L, Durett, April G, Goss, John, Huls, M. Helen, Liu, Zhensheng, Teresita, Lopez, Gee, Adrian P, Ling, Paul D, Brenner, Malcolm K, Heslop, Helen E, Rooney, Cliona M

    Published in The Journal of immunology (1950) (15-01-2002)
    “…Adoptive immunotherapy with EBV-specific CTL (EBV-CTL) effectively prevents and treats EBV-driven lymphoproliferation in immunocompromised hosts…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Flow Cytometric Analysis of Specimens by a Central Reference Laboratory in a Multi-Center Study: Factors Affecting Data Quality by Durett, April G., Gee, Adrian P., Collins, Nancy H., Eapen, Mary, Weisdorf, Daniel

    Published in Blood (16-11-2006)
    “…Central reference flow cytometry laboratories are used in multicenter trials to eliminate inter laboratory variation in testing. Yet, factors that materially…”
    Get full text
    Journal Article
  17. 17

    Identification of megakaryocyte precursors in peripheral blood stem cell collections from normal donors by Bojko, Peter, Hester, Jeane P., Durett, April G., Maadani, Farzaneh, Körbling, Martin, Champlin, Richard E.

    Published in Journal of clinical apheresis (1998)
    “…Platelet engraftment, the time course and magnitude of platelet recovery (PR) post‐transplant, is imprecisely defined but is most often reported as the time to…”
    Get full text
    Journal Article